97. Ulcerative colitis Clinical trials / Disease details

Clinical trials : 2,527 / Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

6 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04991324 (ClinicalTrials.gov)	September 2022	27/7/2021	Cholecalciferol Comedication in IBD - the 5C Study	Cholecalciferol Comedication in Chronic Inflammatory Bowel Diseases (Crohn's Disease or Ulcerative Colitis) - the 5C Study	Inflammatory Bowel Diseases	Drug: Vitamin D3	University Hospital, Basel, Switzerland	NULL	Not yet recruiting	18 Years	N/A	All	150	Phase 3	NULL
2	NCT04331639 (ClinicalTrials.gov)	November 1, 2020	23/3/2020	High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy	Implementation of High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Infliximab or Vedolizumab	Inflammatory Bowel Disease;Crohn Disease;Ulcerative Colitis;Vitamin D Deficiency	Dietary Supplement: vitamin D3	Boston Children's Hospital	NULL	Recruiting	5 Years	25 Years	All	50	Phase 2	United States
3	NCT04225819 (ClinicalTrials.gov)	October 1, 2020	3/1/2020	Adjunctive Treatment With Vitamin D3 in Patients With Active IBD	Adjunctive Treatment With Vitamin D3 in Patients With Active IBD (ACTIVATED): A Randomized, Double-blind, Placebo-controlled Trial	IBD;Inflammatory Bowel Diseases;Crohn Disease;Ulcerative Colitis;Vitamin D3 Deficiency	Dietary Supplement: Vitamin D3;Other: Placebo	Massachusetts General Hospital	NULL	Recruiting	18 Years	N/A	All	100	N/A	United States
4	NCT03162432 (ClinicalTrials.gov)	August 1, 2017	15/5/2017	High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade	High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade	IBD;Ulcerative Colitis;Crohn Disease	Drug: Vitamin D3	Boston Children's Hospital	NULL	Completed	7 Years	25 Years	All	50	Phase 3	United States
5	NCT01640496 (ClinicalTrials.gov)	July 2012	11/7/2012	Vitamin D Treatment in Ulcerative Colitis	Vitamin D Treatment in Ulcerative Colitis	Ulcerative Colitis;Inflammatory Bowel Disease	Drug: Vitamin D3;Other: Placebo	University of Chicago	North Shore University Hospital	Withdrawn	18 Years	N/A	Both	0	N/A	United States
6	NCT01877577 (ClinicalTrials.gov)	April 2012	11/6/2013	Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D	Supplementation of Vitamin D3 (Cholecalciferol) in Patients With Inflammatory Bowel Diseases (IBD) and Hypovitaminosis D: A Prospective Randomized Controlled Trial.	Crohn's Disease (CD);Ulcerative Colitis (UC)	Dietary Supplement: Vitamin D3	University of California, San Francisco	NULL	Completed	18 Years	N/A	Both	30	N/A	United States